Importantly, in the multivariate MR analysis, the ApoB/ApoA1 ratio demonstrated a nominally significant association with metabolic disorders, including T2DM and CKD (all P < 0.05, PFDR>0.05). This evidence concerns the gene APOA1 and type 2 diabetes mellitus.